Memo Therapeutics
Biotechnology company discovering and developing fully human antibodies from immune memory B cells for the treatment of infectious diseases and other therapeutic areas.
Location
Basel, Switzerland
Founded
2018
Investors
1
Categories
biotech, antibody-therapeutics, infectious-disease, immunology, vaccines
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Adjuvant Capital | Washington, DC, USA | biotech-focused | seedseries-a+3 | 16 |